100 related articles for article (PubMed ID: 26597054)
1. PRL-3 activates mTORC1 in Cancer Progression.
Ye Z; Al-Aidaroos AQ; Park JE; Yuen HF; Zhang SD; Gupta A; Lin Y; Shen HM; Zeng Q
Sci Rep; 2015 Nov; 5():17046. PubMed ID: 26597054
[TBL] [Abstract][Full Text] [Related]
2. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
3. p53 Deletion or Hotspot Mutations Enhance mTORC1 Activity by Altering Lysosomal Dynamics of TSC2 and Rheb.
Agarwal S; Bell CM; Taylor SM; Moran RG
Mol Cancer Res; 2016 Jan; 14(1):66-77. PubMed ID: 26385560
[TBL] [Abstract][Full Text] [Related]
4. Estrogen-induced activation of mammalian target of rapamycin is mediated via tuberin and the small GTPase Ras homologue enriched in brain.
Yu J; Henske EP
Cancer Res; 2006 Oct; 66(19):9461-6. PubMed ID: 17018601
[TBL] [Abstract][Full Text] [Related]
5. Rheb and Rags come together at the lysosome to activate mTORC1.
Groenewoud MJ; Zwartkruis FJ
Biochem Soc Trans; 2013 Aug; 41(4):951-5. PubMed ID: 23863162
[TBL] [Abstract][Full Text] [Related]
6. Ceramide inhibits insulin-stimulated Akt phosphorylation through activation of Rheb/mTORC1/S6K signaling in skeletal muscle.
Hsieh CT; Chuang JH; Yang WC; Yin Y; Lin Y
Cell Signal; 2014 Jul; 26(7):1400-8. PubMed ID: 24650522
[TBL] [Abstract][Full Text] [Related]
7. Proton-assisted amino acid transporter PAT1 complexes with Rag GTPases and activates TORC1 on late endosomal and lysosomal membranes.
Ögmundsdóttir MH; Heublein S; Kazi S; Reynolds B; Visvalingam SM; Shaw MK; Goberdhan DC
PLoS One; 2012; 7(5):e36616. PubMed ID: 22574197
[TBL] [Abstract][Full Text] [Related]
8. Orexin/hypocretin activates mTOR complex 1 (mTORC1) via an Erk/Akt-independent and calcium-stimulated lysosome v-ATPase pathway.
Wang Z; Liu S; Kakizaki M; Hirose Y; Ishikawa Y; Funato H; Yanagisawa M; Yu Y; Liu Q
J Biol Chem; 2014 Nov; 289(46):31950-31959. PubMed ID: 25278019
[TBL] [Abstract][Full Text] [Related]
9. A comprehensive immunohistochemical and molecular approach to the PI3K/AKT/mTOR (phosphoinositide 3-kinase/v-akt murine thymoma viral oncogene/mammalian target of rapamycin) pathway in bladder urothelial carcinoma.
Korkolopoulou P; Levidou G; Trigka EA; Prekete N; Karlou M; Thymara I; Sakellariou S; Fragkou P; Isaiadis D; Pavlopoulos P; Patsouris E; Saetta AA
BJU Int; 2012 Dec; 110(11 Pt C):E1237-48. PubMed ID: 23107319
[TBL] [Abstract][Full Text] [Related]
10. Rheb, an activator of target of rapamycin, in the blackback land crab, Gecarcinus lateralis: cloning and effects of molting and unweighting on expression in skeletal muscle.
MacLea KS; Abuhagr AM; Pitts NL; Covi JA; Bader BD; Chang ES; Mykles DL
J Exp Biol; 2012 Feb; 215(Pt 4):590-604. PubMed ID: 22279066
[TBL] [Abstract][Full Text] [Related]
11. Suppression of the GTPase-activating protein RGS10 increases Rheb-GTP and mTOR signaling in ovarian cancer cells.
Altman MK; Alshamrani AA; Jia W; Nguyen HT; Fambrough JM; Tran SK; Patel MB; Hoseinzadeh P; Beedle AM; Murph MM
Cancer Lett; 2015 Dec; 369(1):175-83. PubMed ID: 26319900
[TBL] [Abstract][Full Text] [Related]
12. Gankyrin activates mTORC1 signaling by accelerating TSC2 degradation in colorectal cancer.
Qin X; Wang X; Liu F; Morris LE; Wang X; Jiang B; Zhang Y
Cancer Lett; 2016 Jun; 376(1):83-94. PubMed ID: 26975632
[TBL] [Abstract][Full Text] [Related]
13. Metabolism. Differential regulation of mTORC1 by leucine and glutamine.
Jewell JL; Kim YC; Russell RC; Yu FX; Park HW; Plouffe SW; Tagliabracci VS; Guan KL
Science; 2015 Jan; 347(6218):194-8. PubMed ID: 25567907
[TBL] [Abstract][Full Text] [Related]
14. TSC2 mediates hyperosmotic stress-induced inactivation of mTORC1.
Plescher M; Teleman AA; Demetriades C
Sci Rep; 2015 Sep; 5():13828. PubMed ID: 26345496
[TBL] [Abstract][Full Text] [Related]
15. Gβγ interacts with mTOR and promotes its activation.
Robles-Molina E; Dionisio-Vicuña M; Guzmán-Hernández ML; Reyes-Cruz G; Vázquez-Prado J
Biochem Biophys Res Commun; 2014 Feb; 444(2):218-23. PubMed ID: 24462769
[TBL] [Abstract][Full Text] [Related]
16. Regulation of mTORC1 by PI3K signaling.
Dibble CC; Cantley LC
Trends Cell Biol; 2015 Sep; 25(9):545-55. PubMed ID: 26159692
[TBL] [Abstract][Full Text] [Related]
17. Key mediators of intracellular amino acids signaling to mTORC1 activation.
Duan Y; Li F; Tan K; Liu H; Li Y; Liu Y; Kong X; Tang Y; Wu G; Yin Y
Amino Acids; 2015 May; 47(5):857-67. PubMed ID: 25701492
[TBL] [Abstract][Full Text] [Related]
18. Requirement for lysosomal localization of mTOR for its activation differs between leucine and other amino acids.
Averous J; Lambert-Langlais S; Carraro V; Gourbeyre O; Parry L; B'Chir W; Muranishi Y; Jousse C; Bruhat A; Maurin AC; Proud CG; Fafournoux P
Cell Signal; 2014 Sep; 26(9):1918-27. PubMed ID: 24793303
[TBL] [Abstract][Full Text] [Related]
19. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers.
Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D
Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954
[TBL] [Abstract][Full Text] [Related]
20. Amino acid-dependent NPRL2 interaction with Raptor determines mTOR Complex 1 activation.
Kwak SS; Kang KH; Kim S; Lee S; Lee JH; Kim JW; Byun B; Meadows GG; Joe CO
Cell Signal; 2016 Feb; 28(2):32-41. PubMed ID: 26582740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]